Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma

Journal of Geriatric Oncology(2021)10.1016/j.jgo.2021.02.009Source: DataRank Database

Bortezomib in first-line therapy is associated with falls in older adults with multiple myeloma is a research paper published in Journal of Geriatric Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.79)OA: greenTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Mark A. Fiala ORCID,Tanya M. Wildes ORCID,Kelly L. Schoenbeck ORCID

Live enrichment

PubMed:33750674 PMC:PMC8419206 OpenAlex:https://openalex.org/W3134005956

National Center for Advancing Translational Sciences

Grant: R24 HS19455

Institute of Clinical and Translational Sciences

Grant: UL1 TR002345

National Cancer Institute

Grant: K12CA167540

AHRQ HHS

Grant: R24 HS019455

National Institutes of Health

Grant: 1R24HS019455-01

WASHINGTON UNIVERSITY COMPARATIVE EFFECTIVENESS ADMINISTRATIVE DATA REPOSITORY

National Institutes of Health

Grant: 1UL1TR002345-01

Washington University Institute of Clinical and Translational Sciences

National Institutes of Health

Grant: 5K12CA167540-10

Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology

Agency for Healthcare Research and Quality

American Society of Hematology

National Institutes of Health

National Center for Research Resources

FWCI

0.79

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8419206

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419206

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8419206

publisherhttps://api.elsevier.com/content/article/PII:S1879406821000187?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1879406821000187?httpAccept=text/plain

Fields of Study

Multiple Myeloma Research and TreatmentsCancer Treatment and PharmacologyMyeloproliferative Neoplasms: Diagnosis and TreatmentMedicine03 medical and health sciences0302 clinical medicineAccidental FallsAgedAntineoplastic Combined Chemotherapy ProtocolsBortezomibHumansMedicareMultiple MyelomaProspective StudiesUnited States

MeSH Terms

Accidental FallsBortezomibAgedAntineoplastic Combined Chemotherapy ProtocolsMedicareHumansMultiple MyelomaProspective StudiesUnited States

Keywords

MedicineBortezomibMultiple myelomaPeripheral neuropathyInternal medicineOncologyFirst line therapyFirst lineEndocrinologyElderlyGeriatric AssessmentAccidental FallsAgingClinical SciencesOncology and CarcinogenesisMedicareRare DiseasesClinical ResearchAntineoplastic Combined Chemotherapy ProtocolsHumansProspective StudiesCancerAgedBiomedical and Clinical SciencesPreventionEvaluation of treatments and therapeutic interventionsHematologyUnited States6.1 PharmaceuticalsPatient Safety

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being